LSERS
ENTA icon

Louisiana State Employees Retirement System’s Enanta Pharmaceuticals ENTA Stock Holding History

Louisiana State Employees Retirement System’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,400
Closed -$223K – 1528
2023
Q2 		$223K Buy
10,400
+1,200
+13% +$35.4K ﹤0.01% 1494
2023
Q1 		$372K Sell
9,200
-100
-1% -$4.78K 0.01% 1344
2022
Q4 		$433K Hold
9,300
– – 0.01% 1293
2022
Q3 		$482K Buy
9,300
+400
+4% +$23.4K 0.01% 1201
2022
Q2 		$454K Hold
8,900
– – 0.01% 1287
2022
Q1 		$675K Buy
8,900
+200
+2% +$13K 0.02% 1166
2021
Q4 		$651K Hold
8,700
– – 0.01% 1201
2021
Q3 		$494K Buy
8,700
+600
+7% +$29.7K 0.01% 1303
2021
Q2 		$356K Sell
8,100
-100
-1% -$4.9K 0.01% 1401
2021
Q1 		$404K Hold
8,200
– – 0.01% 1342
2020
Q4 		$345K Sell
8,200
-100
-1% -$4.4K 0.01% 1331
2020
Q3 		$380K Buy
8,300
+3,890
+88% +$188K 0.02% 1136
2020
Q2 		$221K Hold
4,410
– – 0.01% 1191
2020
Q1 		$227K Sell
4,410
-1,060
-19% -$56.5K 0.02% 1063
2019
Q4 		$338K Sell
5,470
-430
-7% -$26.7K 0.02% 1191
2019
Q3 		$354K Hold
5,900
– – 0.02% 1168
2019
Q2 		$500K Hold
5,900
– – 0.03% 985
2019
Q1 		$564K Buy
5,900
+19
+0.3% +$1.7K 0.03% 934
2018
Q4 		$417K Sell
5,881
-1,019
-15% -$78.1K 0.02% 1046
2018
Q3 		$590K Buy
6,900
+400
+6% +$40.1K 0.03% 1059
2018
Q2 		$753K Buy
6,500
+100
+2% +$9.98K 0.03% 852
2018
Q1 		$518K Buy
6,400
+300
+5% +$23.1K 0.02% 1083
2017
Q4 		$358K Buy
6,100
+300
+5% +$15K 0.02% 1265
2017
Q3 		$271K Buy
5,800
+100
+2% +$4.02K 0.01% 1334
2017
Q2 		$205K Buy
+5,700
New +$182K 0.01% 1393
2015
Q4 		– Sell
-5,800
Closed -$210K – 1443
2015
Q3 		$210K Buy
+5,800
New +$249K 0.01% 1352

Other funds holding ENTA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Louisiana State Employees Retirement System's ENTA Position: Q3 2023 in Review

Louisiana State Employees Retirement System sold out of Enanta Pharmaceuticals (ENTA) in Q3 2023, closing a stake of 10,400 shares — an estimated $223K sold.

Louisiana State Employees Retirement System first reported a position in ENTA in Q3 2015 and held it in 26 quarters. The position peaked at $753K in Q2 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q3 2023.

  • Louisiana State Employees Retirement System reported no remaining Enanta Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 10,400 Enanta Pharmaceuticals shares in Q3 2023, an estimated $223K.
  • Louisiana State Employees Retirement System first reported a position in Enanta Pharmaceuticals in Q3 2015 and held it in 26 quarters.
  • Louisiana State Employees Retirement System's Enanta Pharmaceuticals position peaked at $753K in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2023.

Based on Louisiana State Employees Retirement System's 13F filing for Q3 2023, filed 17 Oct 2023.